fbpx ERC: a showcase of excellence | Science in the net

ERC: a showcase of excellence

Primary tabs

di Francesco Aiello, Michele Bellone, Giuseppe Nucera
Pubblicato il 25/10/2014Read time: 1 min
Research and development

The European Research Council (ERC) is a key element in the EU's research funding programme. "Our main aim is to push researchers to be ambitious," told us Jean-Pierre Bourguignon, president of the ERC.

We reached Bourguignon in Genoa, at the Festival della Scienza, where he explained the ERC programme and introduced three researchers who have won an ERC grants. These scientists showed the results they have obtained with their studies: from the mechanisms of time's perception in the human brain to the investigation of Earth's formation through the analysis of diamonds, till the development of touchless, floating displays. We asked them some questions about their work and the ERC grants.


Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


  • 21749 reads

prossimo articolo

Just one move to ward off flu. An Italian discovery

di Elisa Vicenzi
Pubblicato il 03/11/2014
Global Health
Infections

As every year, the winter season is synonymous of influenza viruses causing health problems and significant economic losses for public and private companies. One small, but not negligible, percentage will incur in complications and, potentially, there will also be an increase in mortality for new-borns and elderly patients, caused by the same virus. The vaccine against the seasonal influenza virus strain protects with an effectiveness estimated between 75 and 80 percent – therefore quite good – but not complete. Besides, the vaccination must be